Senior insider sale
EVP, Chief Financial Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$11.63M
345.81K shares
What this filing means
KALIF ELIYAHU SHARON plans to sell 345.81K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $11.63M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/26/2026ACC: 0001973379-26-000052
Officer· EVP, Chief Financial Officer
Since Dec 2019
345.81K
Shares to sell
$11.63M
Approx. market value
345.81K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months6
SHARES FROM ROLLOVER
COMPENSATION
3/5/2025
21.39KSHARES FROM ROLLOVER
COMPENSATION
3/4/2025
182.45KSHARES FROM ROLLOVER
COMPENSATION
3/3/2025
49.80KSHARES FROM ROLLOVER
COMPENSATION
3/5/2024
52.32KSHARES FROM ROLLOVER
COMPENSATION
3/4/2024
27.54KSHARES FROM ROLLOVER
COMPENSATION
2/28/2023
12.31KTotal acquired345.81K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/5/2025 | SHARES FROM ROLLOVER COMPENSATION | 21.39K | — |
3/4/2025 | SHARES FROM ROLLOVER COMPENSATION | 182.45K | — |
3/3/2025 | SHARES FROM ROLLOVER COMPENSATION | 49.80K | — |
3/5/2024 | SHARES FROM ROLLOVER COMPENSATION | 52.32K | — |
3/4/2024 | SHARES FROM ROLLOVER COMPENSATION | 27.54K | — |
2/28/2023 | SHARES FROM ROLLOVER COMPENSATION | 12.31K | — |
| Total | 345.81K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
345.81K
Market value
$11.63M
2/26/2026
Total
Units
345.81K
Value
$11.63M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/26/2026 | 345.81K | $11.63M | NYSE | Planned |
| Total | 345.81K | $11.63M | ||